FITY (Fifty 1 Labs) Equity-to-Asset: -4.44 (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Fifty 1 Labs Equity-to-Asset?

Fifty 1 Labs FITY Equity-to-Asset is -4.44 as of Jun. 2024.

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Fifty 1 Labs's Total Stockholders Equity for the quarter that ended in Jun. 2024 was $-0.12 Mil. Fifty 1 Labs's Total Assets for the quarter that ended in Jun. 2024 was $0.03 Mil.

The historical rank and industry rank for Fifty 1 Labs's Equity-to-Asset or its related term are showing as below:

FITY's Equity-to-Asset is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.61
* Ranked among companies with meaningful Equity-to-Asset only.

Fifty 1 Labs  (OTCPK:FITY) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.

Fifty 1 Labs Equity-to-Asset Related Terms

Fifty 1 Labs Equity-to-Asset Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs Equity-to-Asset Chart

Fifty 1 Labs Annual Data
Trend Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.94 0.00 -6.23 -6.15 -4.44

Fifty 1 Labs Semi-Annual Data
Dec03 Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -1.94 0.00 -6.23 -6.15 -4.44

FITY vs GRPS, KOAN, PTPI: Equity-to-Asset Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fifty 1 Labs's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Fifty 1 Labs Equity-to-Asset vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fifty 1 Labs's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where Fifty 1 Labs's Equity-to-Asset falls into.


Fifty 1 Labs Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

Fifty 1 Labs's Equity to Asset Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Equity to Asset (A: Jun. 2024 )=Total Stockholders Equity/Total Assets
=-0.12/0.027
=

Fifty 1 Labs's Equity to Asset Ratio for the quarter that ended in Jun. 2024 is calculated as

Equity to Asset (Q: Jun. 2024 )=Total Stockholders Equity/Total Assets
=-0.12/0.027
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Equity-to-Asset →
What does a Equity-to-Asset of -4.44 mean?
Fifty 1 Labs (FITY) has a Equity-to-Asset of -4.44 as of Jun. 2024. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' Equity-to-Asset too high?
Fifty 1 Labs' current Equity-to-Asset is -4.44.
How does Fifty 1 Labs' Equity-to-Asset compare to GRPS and KOAN?
Fifty 1 Labs' Equity-to-Asset of -4.44 can be compared against companies in the Drug Manufacturers industry. The industry median Equity-to-Asset is 0.61. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.61, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Fifty 1 Labs and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fifty 1 Labs's current Equity-to-Asset is -4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current Equity-to-Asset of -4.44. The current Equity-to-Asset is -4.44. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current Equity-to-Asset is -4.44 as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.